Skip to Main Content

Paper Details

Risk factors for cardiovascular disease among individuals with hepatic steatosis.
Hepatol Commun
2
2022
Author NameAffiliation
Maros FerencikCardiovascular Imaging Research Center, Harvard Medical School, Massachusetts General Hospital
Maros FerencikKnight Cardiovascular Institute, Oregon Health and Science University
Geoffrey S GinsburgDuke Molecular Physiology Institute, Duke University
Deepak VooraDuke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine
Svati H ShahDuke Molecular Physiology Institute, Duke University
Svati H ShahDuke Clinical Research Institute, Duke University School of Medicine
Svati H ShahDuke Molecular Physiology Institute, Duke University
Svati H ShahDuke Clinical Research Institute, Duke University School of Medicine
Pamela S DouglasDuke Clinical Research Institute, Duke University School of Medicine
  • 1 - 9

Datasets